Patents by Inventor Christopher Casciano

Christopher Casciano has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating multidrug resistance
    Publication number: 20040176403
    Abstract: Methods are provided for treating multidrug resistance in refractory tumor cells comprising administering (1) a P-glycoprotein inhibitor in conjunction with (2) an antineoplastic agent.
    Type: Application
    Filed: March 3, 2004
    Publication date: September 9, 2004
    Inventors: William W. Johnson, Er-Jia Wang, Christopher Casciano, Roger P. Clement
  • Methods for treating multidrug resistance
    Patent number: 6703400
    Abstract: Methods are provided for treating multidrug resistance in refractory tumor cells comprising administering (1) a P-glycoprotein inhibitor in conjunction with (2) an antineoplastic agent.
    Type: Grant
    Filed: March 22, 2002
    Date of Patent: March 9, 2004
    Assignee: Schering Corporation
    Inventors: William W. Johnson, Er-Jia Wang, Christopher Casciano, Robert P. Clement
  • Methods for treating multidrug resistance
    Publication number: 20030216422
    Abstract: Methods are provided for treating multidrug resistance in refractory tumor cells comprising administering (1) a P-glycoprotein inhibitor in conjunction with (2) an antineoplastic agent.
    Type: Application
    Filed: March 22, 2002
    Publication date: November 20, 2003
    Applicant: Schering Corporation
    Inventors: William W. Johnson, Er-Jia Wang, Christopher Casciano, Roger P. Clement
  • Treating allergic and inflammatory conditions
    Patent number: 6599913
    Abstract: A method of treating and/or preventing allergic and inflammatory conditions of the skin or airway passages in a human in need of such treating and/or preventing which comprises administering to said human an effective amount of a nonsedating antihistamine for such treating and/or preventing while avoiding the side effects associated with other nonsedating antihistamines that bind to the P-glycoprotein pump and/or the organic anion transport polypeptide pump is disclosed.
    Type: Grant
    Filed: June 21, 2002
    Date of Patent: July 29, 2003
    Assignee: Schering Corporation
    Inventors: William W. Johnson, Er-Jia Wang, Christopher Casciano, Robert P. Clement